Prevalence and Molecular Characterization of Second-Line Drugs Resistance among Multidrug-Resistant Mycobacterium tuberculosis Isolates in Southwest of China
Table 3
Patterns of drug resistance to second- drugs among 156 isolates from Southwest of China.
Patterns
Number of isolates ()
Number (%)
Monoresistant
43
27.56
OFX
34
21.79
KAN
1
0.64
PTO
2
1.28
PAS
6
3.85
Multiresistant
38
24.36
OFX + KAN
3
1.92
OFX + KAN + AMK
2
1.28
OFX + KAN + CAP
1
0.64
OFX + KAN + PAS
1
0.64
OFX + KAN + CAP + AMK
4
2.56
OFX + KAN + PTO + AMK
1
0.64
OFX + KAN + PTO + PAS + AMK
1
0.64
OFX + KAN + CAP + PAS + AMK
5
3.21
OFX + KAN + CAP + PTO + PAS + AMK
1
0.64
OFX + AMK
1
0.64
OFX + PTO
5
3.21
OFX + PAS
7
4.49
KAN + AMK
2
1.28
KAN + CAP + AMK
2
1.28
KAN + PTO + AMK
1
0.64
KAN + PAS
1
0.64
Susceptible
75
48.08
second-line drugs are as follows: OFX, KAN, AMK, CAP, PTO, or PAS; is defined as Mycobacterium tuberculosis strains resistant to at least isoniazid and rifampin.
